Oncolytics Biotech Inc. Stock Toronto S.E.
Equities
CA6823101077
Biotechnology & Medical Research
Sales 2024 * | 857K 627K | Sales 2025 * | 6.68M 4.88M | Capitalization | 111M 81.04M |
---|---|---|---|---|---|
Net income 2024 * | -36M -26.32M | Net income 2025 * | -40M -29.24M | EV / Sales 2024 * | 129 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 16.6 x |
P/E ratio 2024 * |
-3.31
x | P/E ratio 2025 * |
-3.34
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |